Literature DB >> 9748670

Neurofibrillary tangles and Alzheimer's disease.

J P Brion1.   

Abstract

The neuropathological diagnosis of Alzheimer's disease relies on the presence of both neurofibrillary tangles and senile plaques. The number of neurofibrillary tangles is tightly linked to the degree of dementia, suggesting that the formation of neurofibrillary tangles more directly correlates with neuronal dysfunction. The regional pattern of areas affected by neurofibrillary tangles formation during the course of the disease is relatively stereotyped. Neurofibrillary tangles are composed of highly phosphorylated forms of the microtubule-associated protein tau. Phosphorylated tau proteins accumulate early in neurons, even before formation of neurofibrillary tangles, suggesting that an imbalance between the activities of protein kinases and phosphatases acting on tau is an early phenomenon. The latter might be related to changes in signalling through transduction cascades, since many of the protein kinases generating phosphorylated tau species participate in signalling pathways. The accumulation of neurofibrillary tangles and phosphorylated tau species is associated with disturbances of the microtubule network and, as a consequence of the latter, of axoplasmic flows. The mechanistic relationship between the formation of neurofibrillary tangles and senile plaques is still little understood and in vivo formation of neurofibrillary tangles in experimental models has not yet been achieved. Future animal models, e.g. transgenic animals expressing combined key human proteins, will hopefully reproduce faithfully all the major cellular lesions of the disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9748670     DOI: 10.1159/000007969

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  47 in total

Review 1.  A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.

Authors:  N Chernoff; D J Hill; D L Diggs; B D Faison; B M Francis; J R Lang; M M Larue; T-T Le; K A Loftin; J N Lugo; J E Schmid; W M Winnik
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-06-09       Impact factor: 6.393

2.  Glycation of Lys-16 and Arg-5 in amyloid-β and the presence of Cu2+ play a major role in the oxidative stress mechanism of Alzheimer's disease.

Authors:  Sebastian M Fica-Contreras; Sydney O Shuster; Nathaniel D Durfee; Gregory J K Bowe; Nathaniel J Henning; Staci A Hill; Geoffrey D Vrla; David R Stillman; Kelly M Suralik; Roger K Sandwick; Sunhee Choi
Journal:  J Biol Inorg Chem       Date:  2017-10-16       Impact factor: 3.358

Review 3.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

4.  Leaky endosomes push tau over the seed limit.

Authors:  Chris Ugbode; Laura Fort-Aznar; Sean T Sweeney
Journal:  J Biol Chem       Date:  2019-12-13       Impact factor: 5.157

5.  Ligand-dependent activation of EphA4 signaling regulates the proteolysis of amyloid precursor protein through a Lyn-mediated pathway.

Authors:  Wei-Bin Lai; Bo-Jeng Wang; Ming-Kuan Hu; Wen-Ming Hsu; Guor Mour Her; Yung-Feng Liao
Journal:  Mol Neurobiol       Date:  2013-11-12       Impact factor: 5.590

6.  The Gαq/phospholipase Cβ signaling system represses tau aggregation.

Authors:  Osama Garwain; V Siddartha Yerramilli; Kate Romero; Suzanne Scarlata
Journal:  Cell Signal       Date:  2020-04-01       Impact factor: 4.315

Review 7.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

8.  The Adiponectin Homolog Osmotin Enhances Neurite Outgrowth and Synaptic Complexity via AdipoR1/NgR1 Signaling in Alzheimer's Disease.

Authors:  Gwangho Yoon; Shahid Ali Shah; Tahir Ali; Myeong Ok Kim
Journal:  Mol Neurobiol       Date:  2018-01-15       Impact factor: 5.590

9.  Compensating for synaptic loss in Alzheimer's disease.

Authors:  Kamal Abuhassan; Damien Coyle; Ammar Belatreche; Liam Maguire
Journal:  J Comput Neurosci       Date:  2013-06-02       Impact factor: 1.621

10.  MiR-539-5p Decreases amyloid β-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3β Pathways in APP/PS1 Double Transgenic Mice.

Authors:  Yushu Jiang; Yuan Zhang; Li Su
Journal:  Neurotox Res       Date:  2020-05-15       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.